These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 19055478

  • 1. Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer.
    Farina A, Dumonceau JM, Frossard JL, Hadengue A, Hochstrasser DF, Lescuyer P.
    J Proteome Res; 2009 Jan; 8(1):159-69. PubMed ID: 19055478
    [Abstract] [Full Text] [Related]

  • 2. An integrated approach for comparative proteomic analysis of human bile reveals overexpressed cancer-associated proteins in malignant biliary stenosis.
    Lukic N, Visentin R, Delhaye M, Frossard JL, Lescuyer P, Dumonceau JM, Farina A.
    Biochim Biophys Acta; 2014 May; 1844(5):1026-33. PubMed ID: 23872482
    [Abstract] [Full Text] [Related]

  • 3. Bile carcinoembryonic cell adhesion molecule 6 (CEAM6) as a biomarker of malignant biliary stenoses.
    Farina A, Dumonceau JM, Antinori P, Annessi-Ramseyer I, Frossard JL, Hochstrasser DF, Delhaye M, Lescuyer P.
    Biochim Biophys Acta; 2014 May; 1844(5):1018-25. PubMed ID: 23806607
    [Abstract] [Full Text] [Related]

  • 4. Comparative proteomic analysis of human pancreatic juice: methodological study.
    Zhou L, Lu Z, Yang A, Deng R, Mai C, Sang X, Faber KN, Lu X.
    Proteomics; 2007 Apr; 7(8):1345-55. PubMed ID: 17443640
    [Abstract] [Full Text] [Related]

  • 5. Proteomic analysis of human bile and potential applications for cancer diagnosis.
    Farina A, Dumonceau JM, Lescuyer P.
    Expert Rev Proteomics; 2009 Jun; 6(3):285-301. PubMed ID: 19489700
    [Abstract] [Full Text] [Related]

  • 6. Two-dimensional electrophoresis for comparative proteomic analysis of human bile.
    Chen B, Dong JQ, Chen YJ, Wang JM, Tian J, Wang CB, Zou SQ.
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):402-6. PubMed ID: 17690038
    [Abstract] [Full Text] [Related]

  • 7. Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts.
    Cuoghi A, Farina A, Z'graggen K, Dumonceau JM, Tomasi A, Hochstrasser DF, Genevay M, Lescuyer P, Frossard JL.
    J Proteome Res; 2011 May 06; 10(5):2664-70. PubMed ID: 21425880
    [Abstract] [Full Text] [Related]

  • 8. Elevated levels of neutrophil gelatinase-associated lipocalin in bile from patients with malignant pancreatobiliary disease.
    Zabron AA, Horneffer-van der Sluis VM, Wadsworth CA, Laird F, Gierula M, Thillainayagam AV, Vlavianos P, Westaby D, Taylor-Robinson SD, Edwards RJ, Khan SA.
    Am J Gastroenterol; 2011 Sep 06; 106(9):1711-7. PubMed ID: 21670771
    [Abstract] [Full Text] [Related]

  • 9. [Does cholestasis change the clinical usefulness of CA 19-9 in pacreatobiliary cancer?].
    Mery CM, Duarte-Rojo A, Paz-Pineda F, Gómez E, Robles-Díaz G.
    Rev Invest Clin; 2001 Sep 06; 53(6):511-7. PubMed ID: 11921523
    [Abstract] [Full Text] [Related]

  • 10. A step further in the analysis of human bile proteome.
    Farina A, Dumonceau JM, Delhaye M, Frossard JL, Hadengue A, Hochstrasser DF, Lescuyer P.
    J Proteome Res; 2011 Apr 01; 10(4):2047-63. PubMed ID: 21314112
    [Abstract] [Full Text] [Related]

  • 11. Comprehensive proteomic analysis of human bile.
    Barbhuiya MA, Sahasrabuddhe NA, Pinto SM, Muthusamy B, Singh TD, Nanjappa V, Keerthikumar S, Delanghe B, Harsha HC, Chaerkady R, Jalaj V, Gupta S, Shrivastav BR, Tiwari PK, Pandey A.
    Proteomics; 2011 Dec 01; 11(23):4443-53. PubMed ID: 22114102
    [Abstract] [Full Text] [Related]

  • 12. How many cytological examinations should be performed for the diagnosis of malignant biliary stricture via an endoscopic nasobiliary drainage tube?
    Uchida N, Kamada H, Ono M, Aritomo Y, Masaki T, Nakatsu T, Kuriyama S.
    J Gastroenterol Hepatol; 2008 Oct 01; 23(10):1501-4. PubMed ID: 18028351
    [Abstract] [Full Text] [Related]

  • 13. Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses.
    Severino V, Dumonceau JM, Delhaye M, Moll S, Annessi-Ramseyer I, Robin X, Frossard JL, Farina A.
    Gastroenterology; 2017 Aug 01; 153(2):495-504.e8. PubMed ID: 28479376
    [Abstract] [Full Text] [Related]

  • 14. Pre-analytic saliva processing affect proteomic results and biomarker screening of head and neck squamous carcinoma.
    Ohshiro K, Rosenthal DI, Koomen JM, Streckfus CF, Chambers M, Kobayashi R, El-Naggar AK.
    Int J Oncol; 2007 Mar 01; 30(3):743-9. PubMed ID: 17273777
    [Abstract] [Full Text] [Related]

  • 15. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
    Hong SH, Misek DE, Wang H, Puravs E, Giordano TJ, Greenson JK, Brenner DE, Simeone DM, Logsdon CD, Hanash SM.
    Cancer Res; 2004 Aug 01; 64(15):5504-10. PubMed ID: 15289361
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic role of biliary pancreatic elastase for cholangiocarcinoma in patients with cholestasis.
    Chen CY, Tsai WL, Wu HC, Syu MJ, Wu CC, Shiesh SC.
    Clin Chim Acta; 2008 Apr 01; 390(1-2):82-9. PubMed ID: 18252202
    [Abstract] [Full Text] [Related]

  • 17. Proteomic characterization of metabolites, protein adducts, and biliary proteins in rats exposed to 1,1-dichloroethylene or diclofenac.
    Jones JA, Kaphalia L, Treinen-Moslen M, Liebler DC.
    Chem Res Toxicol; 2003 Oct 01; 16(10):1306-17. PubMed ID: 14565772
    [Abstract] [Full Text] [Related]

  • 18. Gallbladder bile tumor marker quantification for detection of pancreato-biliary malignancies.
    Brockmann J, Emparan C, Hernandez CA, Sulkowski U, Dietl KH, Menzel J, Wolters H, Glodny B, Senninger N.
    Anticancer Res; 2000 Oct 01; 20(6D):4941-7. PubMed ID: 11326643
    [Abstract] [Full Text] [Related]

  • 19. Identification of a novel type of CA19-9 carrier in human bile and sera of cancer patients: an implication of the involvement in nonsecretory exocytosis.
    Uozumi N, Gao C, Yoshioka T, Nakano M, Moriwaki K, Nakagawa T, Masuda T, Tanabe M, Miyoshi E.
    J Proteome Res; 2010 Dec 03; 9(12):6345-53. PubMed ID: 20954701
    [Abstract] [Full Text] [Related]

  • 20. Screening for serological biomarkers of pancreatic cancer by two-dimensional electrophoresis and liquid chromatography-tandem mass spectrometry.
    Wang Y, Kuramitsu Y, Yoshino S, Takashima M, Zhang X, Ueno T, Suzuki N, Oka M, Nakamura K.
    Oncol Rep; 2011 Jul 03; 26(1):287-92. PubMed ID: 21519797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.